14 results on '"Talbot, D. C."'
Search Results
2. Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
3. Erratum: Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
4. Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
5. Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours
6. Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma
7. Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
8. A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours
9. Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents
10. A phase 1 study of tazarotene in adults with advanced cancer
11. Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
12. Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha
13. The development of a structured rating schedule (the BAS) to assess skills in breaking bad news
14. Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.